SectorWatch.biz Issues MarketStats on Renal and Medical Device Equities XCR, FMS, MDT, VAR, and NXTM
July 28 2008 - 5:00AM
PR Newswire (US)
IRVINE, Calif., July 28 /PRNewswire/ -- SectorWatch.biz announces
the availability of MarketStats for renal and medical device
equities in the news and driving markets today. MarketStats offers
a perspective on the aforementioned equities and the opportunity
for investors to respond with articles, blogs and opinions.
Investors can view MarketStats by visiting:
http://www.sectorwatch.biz/ -- a division of FiSpace.net, a dynamic
social networking site for investors. Today's MarketStats for renal
and medical device companies include Xcorporeal, Inc. (AMEX:XCR),
Fresenius, Inc. (NYSE:FMS), Medtronic Inc (NYSE:MDT), Varian
Medical Systems (NYSE:VAR), and NxStage Medical (NASDAQ:NXTM). For
a corporate profile on Xcorporeal, Inc. (AMEX:XCR) visit the
following link: http://www.stockupticks.com/profiles/7-26-08.html A
Roth Capital Partners' May 2008 Research Report on Xcorporeal is
available at that page as well. FiSpace.net is the premiere
Internet destination for stock market readers and writers, allowing
individuals to post blogs, articles, messages and more in organized
sector channels, allowing for the effective exchange of ideas. By
posting content on FiSpace.net individuals can acquire F.A.N.S.
(Financial Networked Subscribers) who help increase the author's
influence and standing on the site in an unprecedented way.
SectorWatch.biz is powered by Market Pathways, a leader in the
representation of Small Cap equities for nearly thirty years.
Market Pathways' analyst Brian Kelly holds CRD #2880975. Statements
herein may contain forward-looking statements and are subject to
significant risks and uncertainties affecting results.
SectorWatch.biz, FiSpace.net and StockUpTicks.com are properties of
Market Pathways Financial Relations Inc. (MP). MP provides no
assurance as to the subject company's plans or ability to effect
proposed actions and cannot project capabilities, intent,
resources, or experience. The subject companies have not always
approved the statements made in this report. This report is neither
a solicitation to buy nor an offer to sell securities but is for
information purposes only and should not be used as the basis for
any investment decision. MP is not an investment advisor, analyst
or licensed broker dealer and this report is not investment advice.
MP has been paid ten thousand dollars by Atlanta Capital for
preparation and distribution of this report and other advertising
services over a thirty day period. This constitutes a conflict of
interest as to MP's ability to remain objective in its
communication regarding the subject company. DATASOURCE:
SectorWatch.biz CONTACT: Shannon Squyres, Editor of Market Pathways
- SectorWatch.biz, +1-949-955-0107 Web site:
http://www.marketpathways.com/ http://www.sectorwatch.biz/
http://www.stockupticks.com/profiles/7-26-08.html
Copyright
Xcorporeal, Inc. (AMEX:XCR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Xcorporeal, Inc. (AMEX:XCR)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Xcorporeal, Inc. (American Stock Exchange): 0 recent articles
More Xcorporeal News Articles